NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo may zap bladder tumors without cutting
Disease control Not yet recruitingThis study tests two experimental treatments for people with intermediate-risk bladder cancer that hasn't spread into the muscle. The treatments combine a drug called N-803 with either BCG or gemcitabine, given directly into the bladder. The goal is to see if these combos can mak…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Microscopic clues in bladder cancer may forecast disease course
Knowledge-focused Not yet recruitingThis study examines tissue samples from 100 bladder cancer patients to see if two microscopic features—how deep early tumors invade and small cell clusters at the tumor edge—can predict cancer return, spread, or survival. Researchers will review past medical records and lab slide…
Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC